Project Details
Description
We have developed a new immunotherapy to treat the underlying causes of type 1 diabetes (T1D) while leaving the rest of the immune system intact. To use this in patients, we need better tests to know when immune therapy is working. We will develop new methods to design the therapy and tools to track the relevant immune cells in T1D that work in variable patient groups. The knowledge gained will speed the pace of development and increase the chance of success of immunotherapy in T1D.
| Status | Finished |
|---|---|
| Effective start/end date | 1/2/20 → 31/5/21 |
| Links | https://www.nhmrc.gov.au/funding/data-research/outcomes-funding-rounds |
Funding
- National Science Foundation: US$50,000.00
ASJC Scopus Subject Areas
- Fluid Flow and Transfer Processes
- Computer Science(all)
- Engineering(all)
- Mathematics(all)
- Immunology
- Endocrinology, Diabetes and Metabolism
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.